MACULAR NEURODEGENERATIVE AND VASCULAR CHANGES ON OPTICAL COHERENCE TOMOGRAPHIC ANGIOGRAPHY IN SICKLE CELL DISEASE ARE NOT RELATED TO ITS OCULAR AND SYSTEMIC COMPLICATIONS
- PMID: 39163633
- PMCID: PMC11559964
- DOI: 10.1097/IAE.0000000000004247
MACULAR NEURODEGENERATIVE AND VASCULAR CHANGES ON OPTICAL COHERENCE TOMOGRAPHIC ANGIOGRAPHY IN SICKLE CELL DISEASE ARE NOT RELATED TO ITS OCULAR AND SYSTEMIC COMPLICATIONS
Abstract
Purpose: To evaluate macular abnormalities in sickle cell disease with optical coherence tomographic angiography and to determine associations with sickle cell retinopathy (SCR) and clinical and laboratory characteristics.
Methods: Complete ophthalmic examination was performed in consecutive patients with sickle cell disease (HbSS, HbSC, HbSβ 0 , or HbSβ + genotype), including fundoscopy and macular spectral-domain optical coherence tomography/optical coherence tomographic angiography scans. Sickle cell retinopathy stage was based on fundoscopic examination (without fluorescein angiography) instead of the Goldberg classification because fluorescein angiography was only used in case of tentative diagnosis. Medical/ophthalmological history and hematologic characteristics were retrieved from medical records.
Results: Two hundred and forty-nine eyes of 137 patients were analyzed. The mean age was 33.3 ± 12.4 years (range 15-70 years). Nonproliferative SCR was present in 57 eyes (22.9%) and proliferative SCR in 36 eyes (14.5%). Macular thinning was present in 100 eyes (40.2%) and was associated with lower foveal vessel density of the superficial capillary plexus and deep capillary plexus and with enlargement of the foveal avascular zone area, perimeter, and acircularity index. Age and female sex were associated with lower (para)foveal vessel density in the superficial capillary plexus and deep capillary plexus. No associations were found between SCR presence/severity and macular thinning or vessel density.
Conclusion: Macular abnormalities were common but did not result in visual impairment. No relation with SCR presence/severity was found. Although optical coherence tomographic angiography imaging is suitable for detecting maculopathy, it appears to have no diagnostic value in identifying patients at risk for SCR.
Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Opthalmic Communications Society, Inc.
Conflict of interest statement
R. P. Brandsen has received research grants from Stichting Pupil (Pupil Foundation, The Netherlands) and Stichting UitZicht (UitZicht Foundation, The Netherlands). B. J. Biemond has received research grants from Sanquin, Novartis, GBT/Pfizer, and BMS/Celgene and participated in advisory board meetings of Novartis, BMS/Celgene, Novo Nordisk, CSL Behring, and GBT/Pfizer. E. Nur has received a research grant from Novartis and participated in the advisory board and speakers' bureau of Novartis. R. O. Schlingemann has received research grants from Novartis and Boehringer-Ingelheim and participated in advisory board meetings of Apellis, Boehringer-Ingelheim, and Ciana Therapeutics. None of the remaining authors has any conflicting interests to disclose.
Figures
References
-
- Stevens TS, Busse B, Lee CB, et al. . Sickling hemoglobinopathies; macular and perimacular vascular abnormalities. Arch Ophthalmol 1974;92:455–463. - PubMed
-
- Han IC, Tadarati M, Scott AW. Macular vascular abnormalities identified by optical coherence tomographic angiography in patients with sickle cell disease. JAMA Ophthalmol 2015;133:1337–1340. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical